Allworth Financial LP Kura Oncology, Inc. Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 10 shares of KURA stock, worth $178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 58
82.76%
Holding current value
$178
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding KURA
# of Institutions
184Shares Held
79.6MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$126 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$124 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$104 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$96.5 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$81 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.19B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...